|
1
|
Kelleher AD and Zaunders JJ: Decimated or
missing in action: CD4+ T cells as targets and effectors
in the pathogenesis of primary HIV infection. Curr HIV/AIDS Rep.
3:5–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vergnon-Miszczycha D, Lucht F, Roblin X,
Pozzetto B, Paul S and Bourlet T: Key role played by the gut
associated lymphoid tissue during human immunodeficiency virus
infection. Med Sci (Paris). 31:1092–1101. 2015.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Estes JD, Harris LD, Klatt NR, Tabb B,
Pittaluga S, Paiardini M, Barclay GR, Smedley J, Pung R, Oliveira
KM, et al: Damaged intestinal epithelial integrity linked to
microbial translocation in pathogenic simian immunodeficiency virus
infections. PLoS Pathog. 6:e10010522010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andrew AL, Mahesh M and Ronald SV: The
gastrointestinal tract and AIDS pathogenesis. Gastroenterology.
136:1966–1978. 2009. View Article : Google Scholar
|
|
5
|
Chun TW, Nickle DC, Justement JS, Meyers
JH, Roby G, Hallahan CW, Kottilil S, Moir S, Mican JM, Mullins JI,
et al: Persistence of HIV in gut-associated lymphoid tissue despite
long-term antiretroviral therapy. J Infect Dis. 197:714–720. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heise C, Miller CJ, Lackner A and Dandekar
S: Primary acute simian immunodeficiency virus infection of
intestinal lymphoid tissue is associated with gastrointestinal
dysfunction. J Infect Dis. 169:1116–1120. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vyboh K, Jenabian MA, Mehraj V and Routy
JP: HIV and the gut microbiota, partners in crime: Breaking the
vicious cycle to unearth new therapeutic targets. J Immunol Res.
2015:6141272015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vujkovic-Cvijin I, Dunham RM, Iwai S,
Maher MC, Albright RG, Broadhurst MJ, Hernandez RD, Lederman MM,
Huang Y, Somsouk M, et al: Dysbiosis of the gut microbiota is
associated with HIV disease progression and tryptophan catabolism.
Sci Transl Med. 5:193ra912013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lozupone CA, Li M, Campbell TB, Flores SC,
Linderman D, Gebert MJ, Knight R, Fontenot AP and Palmer BE:
Alterations in the gut microbiota associated with HIV-1 infection.
Cell Host Microbe. 14:329–339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Novati S, Sacchi P, Cima S, Zuccaro V,
Columpsi P, Pagani L, Filice G and Bruno R: General issues on
microbial translocation in HIV-infected patients. Eur Rev Med
Pharmacol Sci. 19:866–878. 2015.PubMed/NCBI
|
|
11
|
Vassallo M, Mercié P, Cottalorda J,
Ticchioni M and Dellamonica P: The role of lipopolysaccharide as a
marker of immune activation in HIV-1 infected patients: A
systematic literature review. Virol J. 9:1742012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Steele AK, Lee EJ, Vestal B, Hecht D, Dong
Z, Rapaport E, Koeppe J, Campbell TB and Wilson CC: Contribution of
intestinal barrier damage, microbial translocation and HIV-1
infection status to an inflammaging signature. PLoS One.
9:e971712014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hunt PW: Role of immune activation in HIV
pathogenesis. Curr HIV/AIDS Rep. 4:42–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hunt PW, Sinclair E, Rodriguez B, Shive C,
Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN,
et al: Gut epithelial barrier dysfunction and innate immune
activation predict mortality in treated HIV infection. J Infect
Dis. 210:1228–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asmuth DM, Pinchuk IV, Wu J, Vargas G,
Chen X, Mann S, Albanese A, Ma ZM, Saroufeem R, Melcher GP, et al:
Role of intestinal myofibroblasts in HIV-associated intestinal
collagen deposition and immune reconstitution following combination
antiretroviral therapy. AIDS. 29:877–888. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nwosu FC, Avershina E, Wilson R and Rudi
K: Gut microbiota in HIV infection: Implication for disease
progression and management. Gastroenterol Res Pract.
2014:8031852014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rice AP: Roles of microRNAs and
long-noncoding RNAs in human immunodeficiency virus replication.
Wiley Interdiscip Rev RNA. 6:661–670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012.PubMed/NCBI
|
|
19
|
Li LM, Wang D and Zen K: MicroRNAs in
drug-induced liver injury. J Clin Transl Hepatol. 2:162–169.
2014.PubMed/NCBI
|
|
20
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:pp. 13944–13949. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiang K, Liu H and Rice AP: miR-132
enhances HIV-1 replication. Virology. 438:1–4. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sung TL and Rice AP: miR-198 inhibits
HIV-1 gene expression and replication in monocytes and its
mechanism of action appears to involve repression of cyclin T1.
PLoS Pathog. 5:e10002632009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang HS, Wu TC, Sang WW and Ruan Z:
MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR)
transactivation by down-regulation of SIRT1. Biochim Biophys Acta.
1823:1017–1023. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Omoto S, Ito M, Tsutsumi Y, Ichikawa Y,
Okuyama H, Brisibe EA, Saksena NK and Fujii YR: HIV-1 nef
suppression by virally encoded microRNA. Retrovirology. 1:442004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaul CD, Ahlawat A and Gupta SD: HIV-1
genome-encoded hiv1-mir-H1 impairs cellular responses to infection.
Mol Cell Biochem. 323:143–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM,
Wu JY, Chen HY, Wang ZW, Qiu GQ and Peng ZH: Identification of
recurrence-related microRNAs in hepatocellular carcinoma following
liver transplantation. Mol Oncol. 6:445–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective miRNA target sites in mammalian mRNAs. Elife.
4:e050052015. View Article : Google Scholar :
|
|
29
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X: miRDB: A microRNA target
prediction and functional annotation database with a wiki
interface. RNA. 14:1012–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Siliciano RF and Greene WC: HIV latency.
Cold Spring Harb Perspect Med. 1:a0070962011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang J, Wang F, Argyris E, Chen K, Liang
Z, Tian H, Huang W, Squires K, Verlinghieri G and Zhang H: Cellular
microRNAs contribute to HIV-1 latency in resting primary
CD4+ T lymphocytes. Nat Med. 13:1241–1247. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nathans R, Chu CY, Serquina AK, Lu CC, Cao
H and Rana TM: Cellular microRNA and P bodies modulate host-HIV-1
interactions. Mol Cell. 34:696–709. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Triboulet R, Mari B, Lin YL, Chable-Bessia
C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P,
Baillat V, et al: Suppression of microRNA-silencing pathway by
HIV-1 during virus replication. Science. 315:1579–1582. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chiang K, Sung TL and Rice AP: Regulation
of cyclin T1 and HIV-1 Replication by microRNAs in resting
CD4+ T lymphocytes. J Virol. 86:3244–3252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding S, Liang Y, Zhao M, Liang G, Long H,
Zhao S, Wang Y, Yin H, Zhang P, Zhang Q and Lu Q: Decreased
microRNA-142-3p/5p expression causes CD4+ T cell
activation and B cell hyperstimulation in systemic lupus
erythematosus. Arthritis Rheum. 64:2953–2963. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stahl HF, Fauti T, Ullrich N, Bopp T,
Kubach J, Rust W, Labhart P, Alexiadis V, Becker C, Hafner M, et
al: miR-155 inhibition sensitizes CD4+ Th cells for TREG
mediated suppression. PLoS One. 4:e71582009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fenoglio C, Cantoni C, De Riz M, Ridolfi
E, Cortini F, Serpente M, Villa C, Comi C, Monaco F, Mellesi L, et
al: Expression and genetic analysis of miRNAs involved in
CD4+ cell activation in patients with multiple
sclerosis. Neurosci Lett. 504:9–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Palin AC, Ramachandran V, Acharya S and
Lewis DB: Human neonatal naive CD4+ T cells have
enhanced activation-dependent signaling regulated by the microRNA
miR-181a. J Immunol. 190:2682–2691. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pan Z, Radding W, Zhou T, Hunter E, Mountz
J and McDonald JM: Role of calmodulin in HIV-potentiated
Fas-mediated apoptosis. Am J Pathol. 149:903–910. 1996.PubMed/NCBI
|
|
42
|
Hall JA, Cannons JL, Grainger JR, Dos
Santos LM, Hand TW, Naik S, Wohlfert EA, Chou DB, Oldenhove G,
Robinson M, et al: Essential role for retinoic acid in the
promotion of CD4(+) T cell effector responses via retinoic acid
receptor alpha. Immunity. 34:435–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Safi R, Muramoto GG, Salter AB, Meadows S,
Himburg H, Russell L, Daher P, Doan P, Leibowitz MD, Chao NJ, et
al: Pharmacological manipulation of the RAR/RXR signaling pathway
maintains the repopulating capacity of hematopoietic stem cells in
culture. Mol Endocrinol. 23:188–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Barbaro G, Di Lorenzo G, Grisorio B and
Barbarini G: Incidence of dilated cardiomyopathy and detection of
HIV in myocardial cells of HIV-positive patients. Gruppo italiano
per lo studio cardiologico dei pazienti affetti da AIDS. N Engl J
Med. 339:1093–1099. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lewis W: Cardiomyopathy in AIDS: A
pathophysiological perspective. Prog Cardiovasc Dis. 43:151–170.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou X, Wang H, Burg MB and Ferraris JD:
Inhibitory phosphorylation of GSK-3β by AKT, PKA, and PI3K
contributes to high NaCl-induced activation of the transcription
factor NFAT5 (TonEBP/OREBP). Am J Physiol Renal Physiol.
304:F908–F917. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Macián F, López-Rodríguez C and Rao A:
Partners in transcription: NFAT and AP-1. Oncogene. 20:2476–2489.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Brocker C, Thompson D, Matsumoto A, Nebert
DW and Vasiliou V: Evolutionary divergence and functions of the
human interleukin (IL) gene family. Hum Genomics. 5:30–55. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Leyme A, Marivin A, Perez-Gutierrez L,
Nguyen LT and Garcia-Marcos M: Integrins activate trimeric G
proteins via the nonreceptor protein GIV/Girdin. J Cell Biol.
210:1165–1184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu Y, Belkina NV and Shaw S: HIV
infection of T cells: Actin-in and actin-out. Sci Signal.
2:pe232009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Blanco J, Bosch B, Fernández-Figueras MT,
Barretina J, Clotet B and Esté JA: High level of
coreceptor-independent HIV transfer induced by contacts between
primary CD4 T cells. J Biol Chem. 279:51305–51314. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sufiawati I and Tugizov SM: HIV-associated
disruption of tight and adherens junctions of oral epithelial cells
facilitates HSV-1 infection and spread. PLoS One. 9:e888032014.
View Article : Google Scholar : PubMed/NCBI
|
